Parsatuzumab (RG 7414) is a humanized monoclonal antibody targeting EGFL7, which is also used as an immunomodulator.Parsatuzumab selectively inhibits the interaction between EGFL7 and endothelial cells, and has an inhibitory effect on endothelial growth
CAS Number:
[1312797-14-0]
Target:
VEGFR
* VAT and and shipping costs not included. Errors and price changes excepted